rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Telomir Pharmaceuticals, Inc.

TELO · Nasdaq

Health CareBiotechnologyNot moving yet

TELO stood above a rising 150-day average in 1 of the last 52 weekly readings, and has been out of that trend for the last 24 weeks. It is 14.8% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 24
Industry in uptrend
15% -17 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
31 (+5)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 1 of 52 weeks.

17 Apr – 16 Oct
16%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1$0$1Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders31+5 on the quarter
New · exited10 · 5
Reported value$3.8M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 20261,613,639$2.1M+618,266+62.1%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026338,875$434K+89,789+36.0%
BlackRock, Inc.reduced · filed 7 Aug 2026280,472$359K-8,726−3.0%
VANGUARD FIDUCIARY TRUST COadded · filed 13 Aug 2026225,304$288K+89,763+66.2%
NORTHERN TRUST CORPadded · filed 13 Aug 202661,532$79K+19,688+47.1%
STATE STREET CORPunchanged · filed 7 Aug 202658,600$75K00.0%
Bank of New York Mellon Corpunchanged · filed 6 Aug 202651,454$66K00.0%
CAPTRUST FINANCIAL ADVISORSnew · filed 13 Aug 202651,194$66K+51,194
OSAIC HOLDINGS, INC.added · filed 14 Aug 202641,490$53K+5,695+15.9%
World Investment Advisorsunchanged · filed 14 Aug 202637,037$48K00.0%
31 Mar 2024 – 30 Jun 2026
72339Mar 24Sep 24Jun 25Dec 25Jun 26

Everyone who traded it

Edward Clouston MacPherson Company insiderDirector · last 21 May 20260 · 0
Erez Aminov Company insiderCEO and Chairman · last 21 May 20260 · 1
Matthew Paul Del Giudice Company insiderDirector · last 21 May 20260 · 0
Matthew Pratt Whalen Company insiderDirector · last 21 May 20260 · 0
Bay Shore Trust Company insider10% owner · last 21 Nov 20240 · 0
Michael Allen Jerman Company insiderDirector · last 27 Aug 20240 · 0
Michelle Yanez Company insiderChief Financial Officer · last 27 Aug 20240 · 0
Brian Patrick McNulty Company insider10% owner · last 13 Feb 20241 · 0

Same industry

MRNA ModernaLeading+147%
IOVA Iovance BiotherapeuticsLeading+126%
ABCL AbCellera BiologicsLeading+60%
HALO Halozyme TherapeuticsLeading+46%
XERS Xeris Biopharma HoldingsLeading+38%
ENTX Entera BioLeading+37%
HELP Helus PharmaLeading+36%
XNCR XencorLeading+30%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Share count trendFY 2025 · to 12 Mar 20260.0%

Analyst forecasts

No analyst forecasts yet.